Systems Biology in ELIXIR: modelling in the spotlight
-
Published:2022-11-07
Issue:
Volume:11
Page:1265
-
ISSN:2046-1402
-
Container-title:F1000Research
-
language:en
-
Short-container-title:F1000Res
Author:
Martins dos Santos Vitor, Anton MihailORCID, Szomolay Barbara, Ostaszewski Marek, Arts Ilja, Benfeitas Rui, Dominguez Del Angel VictoriaORCID, Ferk Polonca, Fey Dirk, Goble Carole, Golebiewski MartinORCID, Gruden Kristina, Heil Katharina F.ORCID, Hermjakob Henning, Kahlem PascalORCID, Klapa Maria I.ORCID, Koehorst Jasper, Kolodkin AlexeyORCID, Kutmon MartinaORCID, Leskošek Brane, Moretti SébastienORCID, Müller Wolfgang, Pagni Marco, Rezen Tadeja, Rocha Miguel, Rozman Damjana, Šafránek DavidORCID, Sheriff Rahuman S. MalikORCID, Suarez Diez MariaORCID, Van Steen Kristel, Westerhoff Hans VORCID, Wittig UlrikeORCID, Wolstencroft KatherineORCID, Zupanic AnzeORCID, Evelo Chris T.ORCID, Hancock John M.ORCID
Abstract
In this white paper, we describe the founding of a new ELIXIR Community - the Systems Biology Community - and its proposed future contributions to both ELIXIR and the broader community of systems biologists in Europe and worldwide. The Community believes that the infrastructure aspects of systems biology - databases, (modelling) tools and standards development, as well as training and access to cloud infrastructure - are not only appropriate components of the ELIXIR infrastructure, but will prove key components of ELIXIR’s future support of advanced biological applications and personalised medicine. By way of a series of meetings, the Community identified seven key areas for its future activities, reflecting both future needs and previous and current activities within ELIXIR Platforms and Communities. These are: overcoming barriers to the wider uptake of systems biology; linking new and existing data to systems biology models; interoperability of systems biology resources; further development and embedding of systems medicine; provisioning of modelling as a service; building and coordinating capacity building and training resources; and supporting industrial embedding of systems biology. A set of objectives for the Community has been identified under four main headline areas: Standardisation and Interoperability, Technology, Capacity Building and Training, and Industrial Embedding. These are grouped into short-term (3-year), mid-term (6-year) and long-term (10-year) objectives.
Publisher
F1000 Research Ltd
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|